Fairvalue-Calculator Fairvalue-Calculator
EN DE

Medeze Group (MEDEZE) Fair Value & Analysis

Healthcare · TH · Market cap 6.5B THB

Price6.50 THB
Fair Value2.79 THB
Upside-57.1%
Quality87/100
Evidence: Medium Range 2.19 THB – 3.16 THB

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Medeze Group (MEDEZE) currently trades at 6.50 THB, while our model-based Fair Value estimate is 2.79 THB — implying the stock looks roughly 57.1% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -25% 5225 (5225) -70% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) -7% Tenet Healthcare Corporation (THC) +74%

Frequently asked questions

Is Medeze Group (MEDEZE) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2.79 THB versus a price of 6.50 THB — about −57% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MEDEZE?
Our 21-model fair value for Medeze Group is 2.79 THB (as of Jun 24, 2026), built from audited fundamentals. The current price is 6.50 THB.
What is the quality score of MEDEZE?
Medeze Group has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.